29
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Effects of Angiotensin-Converting Enzyme (ACE) Inhibitors on Oxygen Radical Production and Generation by Murine Lung Alveolar Macrophages

, , , , &
Pages 665-670 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ioannis E. Vasileiadis, Christos A. Goudis, Pinelopi T. Giannakopoulou & Tong Liu. (2018) Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 148-156.
Read now
Makoto Shimozawa, Yuji Naito, Hiroki Manabe, Kazuhiko Uchiyama, Kazuhiro Katada, Masaaki Kuroda, Nami Nakabe, Norimasa Yoshida & Toshikazu Yoshikawa. (2004) The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-α. Redox Report 9:6, pages 354-359.
Read now

Articles from other publishers (9)

Dominik Felkle, Katarzyna Zięba, Konrad Kaleta, Julia Czaja, Amanda Zyzdorf, Wiktoria Sobocińska, Mateusz Jarczyński, Krzysztof Bryniarski & Katarzyna Nazimek. (2023) Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI. International Immunopharmacology 124, pages 110858.
Crossref
Paweł Bryniarski, Katarzyna Nazimek & Janusz Marcinkiewicz. (2022) Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. International Journal of Molecular Sciences 23:3, pages 1772.
Crossref
James Jiqi Wang, Matthew L. Edin, Darryl C. Zeldin, Chenze Li, Dao Wen Wang & Chen Chen. (2020) Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacology & Therapeutics 215, pages 107628.
Crossref
Keisuke Nakazawa, Naoki Kotani, Kaoru Goto, Minoru Nomura & Makoto Ozaki. (2012) Insertion/deletion polymorphism of the angiotensin-converting enzyme considerably changes postoperative outcome. Journal of Clinical Anesthesia 24:8, pages 631-638.
Crossref
M Gabriella Matera, Luigino Calzetta, Barbara Rinaldi & Mario Cazzola. (2012) Treatment of COPD: moving beyond the lungs. Current Opinion in Pharmacology 12:3, pages 315-322.
Crossref
KIRK U. KNOWLTON, MARIA C. SAVOIA & MICHAEL N. OXMAN. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 1153 1171 .
S Guo, JH Zhang, YD Yan, YF Ding & JY Sheng. (2009) Association between Renin-Angiotensin System Gene Polymorphism and Recurrent Wheezing in Chinese Children: A 4-year Follow-up Study. Journal of International Medical Research 37:2, pages 351-358.
Crossref
M. Van Der Giet, M. Erinola, W. Zidek & M. Tepel. (2002) Captopril and quinapril reduce reactive oxygen species. European Journal of Clinical Investigation 32:10, pages 732-737.
Crossref
Richard P. Marshall, Suzanne Webb, Geoffrey J. Bellingan, Hugh E. Montgomery, Babar Chaudhari, Robin J. McAnulty, Steve E. Humphries, Mike R. Hill & Geoffrey J. Laurent. (2002) Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated with Susceptibility and Outcome in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine 166:5, pages 646-650.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.